<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000782333">
  <TermName>R-ICE</TermName>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat certain types of non-Hodgkin lymphoma. It includes the drugs rituximab, ifosfamide, carboplatin, and etoposide phosphate. Also called R-ICE regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>R-ICE</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento de ciertos tipos de linfoma  no Hodgkin. Incluye los medicamentos rituximab, ifosfamida, carboplatino y fosfato de etopósido. También se llama régimen R-ICE.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2016-07-27</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000782327" url="/about-cancer/treatment/drugs/R-ICE">R-ICE</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
